538 related articles for article (PubMed ID: 33998900)
1. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
2. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
5. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.
Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M
J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
7. The Anti-Inflammatory Effects of
Zaiachuk M; Suryavanshi SV; Pryimak N; Kovalchuk I; Kovalchuk O
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446655
[TBL] [Abstract][Full Text] [Related]
8. Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model.
Szekely Y; Ingbir M; Bentur OS; Hochner O; Porat R
Eur Cytokine Netw; 2020 Jun; 31(2):50-58. PubMed ID: 32933892
[TBL] [Abstract][Full Text] [Related]
9. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
Li D; Ilnytskyy Y; Ghasemi Gojani E; Kovalchuk O; Kovalchuk I
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144796
[No Abstract] [Full Text] [Related]
12. Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons.
Anand U; Oldfield C; Pacchetti B; Anand P; Sodergren MH
J Pain Res; 2021; 14():3603-3614. PubMed ID: 34853533
[TBL] [Abstract][Full Text] [Related]
13. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
Lamanna-Rama N; Romero-Miguel D; Casquero-Veiga M; MacDowell KS; Santa-Marta C; Torres-Sánchez S; Berrocoso E; Leza JC; Desco M; Soto-Montenegro ML
Psychiatry Res; 2024 Jan; 331():115643. PubMed ID: 38064909
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
15. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
16. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Lah TT; Novak M; Pena Almidon MA; Marinelli O; Žvar Baškovič B; Majc B; Mlinar M; Bošnjak R; Breznik B; Zomer R; Nabissi M
Cells; 2021 Feb; 10(2):. PubMed ID: 33562819
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis.
Velayudhan L; McGoohan K; Bhattacharyya S
PLoS Med; 2021 Mar; 18(3):e1003524. PubMed ID: 33780450
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
19. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
